Latest filing published 06 Oct 2023 for Zentalis Pharmaceuticals, Inc., €165k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Carrie Brownstein: trading record in brief
This profile gathers the share dealings of Carrie Brownstein in Zentalis Pharmaceuticals, Inc. In total, 3 filings cover trades dated from 3 October 2022 to 4 October 2023.
Every open-market trade on record is a sale: 1 sale worth €165k. Other entries cover 2 share grants. In 2023 alone, the filings show no purchases and 1 sale.
The newest entry dates from 6 October 2023: an open-market sale of €165k, in Zentalis Pharmaceuticals, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Carrie Brownstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,906 shares@ US$19.4265100.0% of flowCommon StockSEC:0001725160-23-000181:0
- 16,313 shares0Common StockSEC:0001725160-23-000015:0
- 100,000 shares0Common StockSEC:0001725160-22-000178:0
3 of 3 declarations